← FDA DRUG APPROVALS

FDA ANDA · ANDA070088

IBU

Sponsor: BASF

APPLICATION
ANDA070088
TYPE
ANDA
ORIGINAL APPROVAL
1985-02-08
LATEST ACTION
1988-10-07
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

IBUDiscontinued
IBUPROFEN 600MG · TABLET · ORAL

Approval history

1988-10-07Labeling · Supplement 8AP
1988-02-08Labeling · Supplement 7AP
1987-03-24Manufacturing (CMC) · Supplement 6AP
1987-03-24Manufacturing (CMC) · Supplement 4AP
1986-01-22Manufacturing (CMC) · Supplement 3AP
1985-04-09Manufacturing (CMC) · Supplement 2AP
1985-04-09Manufacturing (CMC) · Supplement 1AP
1985-02-08Original — Other ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →